Limitations and Remaining Questions While semaglutide has shown significant benefits in reducing joint pain among patients with obesity, several important limitations remain: Studies often lack post-treatment follow-up, making it unclear how durable these pain and weight outcomes are once medication is stopped
But while people who get their GLP-1s through self-pay programs or other kinds of insurance might be able to switch products, the limited products in the Bridge program mean Medicare participants will have fewer options if manufacturers cant keep up
Always inform your surgical team about your Ozempic use so they can make individualised decisions about your care
Sara Shareef July 27, 2026 Your periods are unpredictable
IGF-1 LR3 has also shown promise in supporting fat metabolism, enhancing physical performance, and improving overall body composition
*** Nutritional values given in the table may slightly vary depending on the batch